Inflammatory Bowel Disease clinical trials

Explore recruiting inflammatory bowel disease clinical trials.

Recruiting inflammatory bowel disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Inflammatory Bowel Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s Fistulas : ADICROHN II

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Multicenter, Double-Blind, Placebo Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy with RO7790121 in Patients with Moderately to Severely Active Crohn's Disease

Italy, France, Belgium, Hungary, Denmark, Romania +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Modafinil for debilitating fatigue in quiescent inflammatory bowel disease: a multicentre, randomised, double-blind, placebo-controlled, clinical trial (MODIFI-IBD trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective Multicenter Randomized Controlled, Open-label Study to Compare the Efficacy of Subcutaneous Infliximab Monotherapy with Subcutaneous Infliximab and Concomitant Immunosuppression in the Treatment of Moderate to Severe Crohn’s Disease ( Direct-CD)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Investigating the safety, feasibility, and optimal dose of fluorescently labeled Adalimumab-680LT for visualizing drug targeting in Inflammatory Bowel Diseases.

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Inflammatory Bowel Disease trials by city

Inflammatory Bowel Disease in Toronto Inflammatory Bowel Disease in Vancouver Inflammatory Bowel Disease in Montreal Inflammatory Bowel Disease in Calgary Inflammatory Bowel Disease in Edmonton Inflammatory Bowel Disease in Ottawa Inflammatory Bowel Disease in Winnipeg Inflammatory Bowel Disease in Quebec City Inflammatory Bowel Disease in Hamilton Inflammatory Bowel Disease in Kitchener Inflammatory Bowel Disease in London Inflammatory Bowel Disease in Halifax Inflammatory Bowel Disease in New York Inflammatory Bowel Disease in Los Angeles Inflammatory Bowel Disease in Chicago Inflammatory Bowel Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease